| Dr Darin Marshall Minkin, DO | |
|
2355 Dougherty Ferry Rd, 430, Saint Louis, MO 63122 | |
| (314) 965-8410 | |
| (314) 965-8756 |
| Full Name | Dr Darin Marshall Minkin |
|---|---|
| Gender | Male |
| Speciality | General Surgery |
| Experience | 25 Years |
| Location | 2355 Dougherty Ferry Rd, Saint Louis, Missouri |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1043296494 | NPI | - | NPPES |
| 209057603 | Medicaid | MO |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208600000X | Surgery | 2000170421 (Missouri) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| St Luke's Des Peres Hospital | Saint louis, MO | Hospital |
| St Lukes Hospital | Chesterfield, MO | Hospital |
| Entity Name | Darin M Minkin Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1255597738 PECOS PAC ID: 7012081284 Enrollment ID: O20080806000216 |
News Archive
Oramed Pharmaceuticals Inc., a developer of oral drug delivery systems, announced today that it will announce the results of its Phase 2a clinical trial for the company's ORMD-0801 oral insulin capsule for the treatment of type 2 diabetes on January 30, 2014.
An experimental treatment that combines a cell-killing radioactive particle with an antibody that homes in on cancer cells is safe in the treatment of cancers spreading through patients' abdomens, according to data from a first-in-human study presented today at the Society of Nuclear Medicine and Molecular Imaging annual meeting in Vancouver.
Pre-eclampsia is associated with increased classical pathway activation and altered complement regulation, suggest Dutch results indicating that the extent of complement dysregulation may be related to the severity of pre-eclampsia.
Undetected osteoporosis in the elderly might be discovered if chest radiographs (x-ray images) that are done for other reasons were examined for fractures of the vertebrae, according to an article in the April 25 issue of Archives of Internal Medicine.
Bioniche Life Sciences Inc., a research-based, technology driven Canadian biopharmaceutical company, today announced that it has met the obligations associated with two milestones under its licensing agreement with Endo Pharmaceuticals for exclusive rights to develop and market Bioniche's proprietary product for non-muscle-invasive bladder cancer in North America.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Darin Marshall Minkin, DO 2355 Dougherty Ferry Rd, 430, Saint Louis, MO 63122-3325 Ph: (314) 965-8410 | Dr Darin Marshall Minkin, DO 2355 Dougherty Ferry Rd, 430, Saint Louis, MO 63122 Ph: (314) 965-8410 |
News Archive
Oramed Pharmaceuticals Inc., a developer of oral drug delivery systems, announced today that it will announce the results of its Phase 2a clinical trial for the company's ORMD-0801 oral insulin capsule for the treatment of type 2 diabetes on January 30, 2014.
An experimental treatment that combines a cell-killing radioactive particle with an antibody that homes in on cancer cells is safe in the treatment of cancers spreading through patients' abdomens, according to data from a first-in-human study presented today at the Society of Nuclear Medicine and Molecular Imaging annual meeting in Vancouver.
Pre-eclampsia is associated with increased classical pathway activation and altered complement regulation, suggest Dutch results indicating that the extent of complement dysregulation may be related to the severity of pre-eclampsia.
Undetected osteoporosis in the elderly might be discovered if chest radiographs (x-ray images) that are done for other reasons were examined for fractures of the vertebrae, according to an article in the April 25 issue of Archives of Internal Medicine.
Bioniche Life Sciences Inc., a research-based, technology driven Canadian biopharmaceutical company, today announced that it has met the obligations associated with two milestones under its licensing agreement with Endo Pharmaceuticals for exclusive rights to develop and market Bioniche's proprietary product for non-muscle-invasive bladder cancer in North America.
› Verified 7 days ago
Dr. Matthew Russell Smeds, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 1225 S Grand Blvd, Saint Louis, MO 63104 Phone: 314-977-4730 Fax: 314-977-1642 | |
Dr. William C Chapman Jr., MD Surgery Medicare: Medicare Enrolled Practice Location: 1044 N Mason Rd, Div Surg Colon/rectal, Ste 310, Saint Louis, MO 63141 Phone: 314-454-7177 Fax: 888-425-7946 | |
Dr. Bradley Kushner, MD Surgery Medicare: Medicare Enrolled Practice Location: 660 S Euclid Ave Fl 9, Saint Louis, MO 63110 Phone: 314-362-2294 | |
Eddy C Hsueh, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 3655 Vista Ave, Saint Louis, MO 63110 Phone: 314-977-4440 Fax: 314-977-1630 | |
Dr. Laurie Jean Punch, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 11133 Dunn Rd, Dept Anesthesiology, Saint Louis, MO 63136 Phone: 800-862-9980 Fax: 314-362-1185 | |
Dr. David Caplin, M.D. Surgery Medicare: Not Enrolled in Medicare Practice Location: 845 N New Ballas Ct, Suite 300, Saint Louis, MO 63141 Phone: 314-569-0130 Fax: 314-569-3674 | |
Dr. Stephen Ray Eaton, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 1 Barnes Jewish Hospital Plz, Saint Louis, MO 63110 Phone: 314-362-5298 Fax: 314-362-5743 |